NasdaqGS - Delayed Quote USD

DENTSPLY SIRONA Inc. (XRAY)

30.57 +0.22 (+0.72%)
At close: April 26 at 4:00 PM EDT
30.62 +0.05 (+0.16%)
After hours: April 26 at 4:36 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,965,000.00
3,965,000.00
3,922,000.00
4,231,000.00
3,339,000.00
Cost of Revenue
1,879,000.00
1,879,000.00
1,795,000.00
1,884,000.00
1,683,000.00
Gross Profit
2,086,000.00
2,086,000.00
2,127,000.00
2,347,000.00
1,656,000.00
Operating Expense
1,804,000.00
1,804,000.00
1,770,000.00
1,722,000.00
1,425,000.00
Operating Income
282,000.00
282,000.00
357,000.00
625,000.00
231,000.00
Net Non Operating Interest Income Expense
-81,000.00
-81,000.00
-65,000.00
-61,000.00
-46,000.00
Other Income Expense
-376,000.00
-376,000.00
-1,347,000.00
-19,000.00
-235,000.00
Pretax Income
-175,000.00
-175,000.00
-1,055,000.00
545,000.00
-50,000.00
Tax Provision
-43,000.00
-43,000.00
-105,000.00
134,000.00
23,000.00
Net Income Common Stockholders
-132,000.00
-132,000.00
-950,000.00
411,000.00
-73,000.00
Diluted NI Available to Com Stockholders
-132,000.00
-132,000.00
-950,000.00
411,000.00
-73,000.00
Basic EPS
-0.62
-0.62
-4.41
1.88
-0.33
Diluted EPS
-0.62
-0.62
-4.41
1.87
-0.33
Basic Average Shares
212,000.00
212,000.00
215,500.00
218,400.00
219,200.00
Diluted Average Shares
212,000.00
212,000.00
215,500.00
220,200.00
219,200.00
Total Operating Income as Reported
-85,000.00
-85,000.00
-937,000.00
608,000.00
-3,000.00
Total Expenses
3,683,000.00
3,683,000.00
3,565,000.00
3,606,000.00
3,108,000.00
Net Income from Continuing & Discontinued Operation
-132,000.00
-132,000.00
-950,000.00
411,000.00
-73,000.00
Normalized Income
147,840.00
147,840.00
229,620.85
423,818.00
88,330.00
Interest Income
--
--
--
--
1,000.00
Interest Expense
81,000.00
81,000.00
65,000.00
61,000.00
46,000.00
Net Interest Income
-81,000.00
-81,000.00
-65,000.00
-61,000.00
-46,000.00
EBIT
-94,000.00
-94,000.00
-990,000.00
606,000.00
-4,000.00
EBITDA
249,000.00
249,000.00
-662,000.00
952,000.00
330,000.00
Reconciled Cost of Revenue
1,879,000.00
1,879,000.00
1,795,000.00
1,884,000.00
1,683,000.00
Reconciled Depreciation
343,000.00
343,000.00
328,000.00
346,000.00
334,000.00
Net Income from Continuing Operation Net Minority Interest
-132,000.00
-132,000.00
-950,000.00
411,000.00
-73,000.00
Total Unusual Items Excluding Goodwill
-371,000.00
-371,000.00
-1,310,000.00
-17,000.00
-221,000.00
Total Unusual Items
-371,000.00
-371,000.00
-1,310,000.00
-17,000.00
-221,000.00
Normalized EBITDA
620,000.00
620,000.00
648,000.00
969,000.00
551,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-91,160.00
-91,160.00
-130,379.15
-4,182.00
-59,670.00
12/31/2020 - 8/12/1987

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TFX Teleflex Incorporated
206.71
0.00%
 
COO The Cooper Companies, Inc.
88.84
-1.21%
 
NVST Envista Holdings Corporation
20.39
+1.85%
 
STMN.SW Straumann Holding AG
138.10
+3.41%
 
ICUI ICU Medical, Inc.
94.84
+0.33%
 
HOLX Hologic, Inc.
75.98
+0.36%
 
ALC Alcon Inc.
78.77
-0.09%
 
UTMD Utah Medical Products, Inc.
65.92
-0.56%
 
STVN Stevanato Group S.p.A.
27.54
+0.07%
 
EMBC Embecta Corp.
10.31
-0.87%